TrialThe oncologist2021

Patient-Reported Outcomes Predict Progression-Free Survival of Patients with Advanced Breast Cancer Treated with Abemaciclib.

Sarah Badaoui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.